MedTrace Logo

Progression of Prodromal Markers of α-synucleinopathy Neurodegeneration in the FDRs of Patients With RBD

NCT03671772 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2021-08-06

No results posted yet for this study

Summary

This study is a prospective study with a mean of 5-year follow-up interval, aims to monitor the progression of α-synucleinopathy neurodegeneration by the evolution of prodromal markers and development of clinical disorders in first-degree relatives (FDRs) of idiopathic REM Sleep Behavior Disorder (RBD) patients and healthy controls.

Conditions

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Jihui Zhang, PhD · Chinese University of Hong Kong

  • Yun Kwok Wing, MBChB · Chinese University of Hong Kong

  • Vincent Chung Tong Mok, MBChB · Chinese University of Hong Kong

  • Shirley Xin Li, PhD · Hong Kong University

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-27
Primary Completion
2020-04-27
Completion
2020-04-27

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03671772 on ClinicalTrials.gov